pubmed-article:12794521 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12794521 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:12794521 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
pubmed-article:12794521 | lifeskim:mentions | umls-concept:C0023452 | lld:lifeskim |
pubmed-article:12794521 | lifeskim:mentions | umls-concept:C0150099 | lld:lifeskim |
pubmed-article:12794521 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:12794521 | pubmed:dateCreated | 2003-6-9 | lld:pubmed |
pubmed-article:12794521 | pubmed:abstractText | In a previous randomized study, the authors reported that granulocyte colony-stimulating factor (G-CSF) increased the chemotherapy dose-intensity delivered during the consolidation therapy of high-risk childhood acute lymphoblastic leukemia (ALL). The aim of the current study was to perform an economic evaluation in the same cohort. | lld:pubmed |
pubmed-article:12794521 | pubmed:language | eng | lld:pubmed |
pubmed-article:12794521 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12794521 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12794521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12794521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12794521 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12794521 | pubmed:month | Jun | lld:pubmed |
pubmed-article:12794521 | pubmed:issn | 1077-4114 | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:BerthouChrist... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:VannierJean-P... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:LeblancThierr... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:BordigoniPier... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:GandemerVirgi... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:LevergerGuyG | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:BaruchelAndré... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:BraguerDianeD | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:PerelYvesY | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:LamagnereJean... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:MichelGérardG | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:AuclercMarie-... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:DelormeJeanJ | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:BadinStéphani... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:Le... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:AuvrignonAnne... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:DemeocqFranço... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:BauduerFranço... | lld:pubmed |
pubmed-article:12794521 | pubmed:author | pubmed-author:PautardBrigit... | lld:pubmed |
pubmed-article:12794521 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12794521 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:12794521 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12794521 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12794521 | pubmed:pagination | 441-7 | lld:pubmed |
pubmed-article:12794521 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:meshHeading | pubmed-meshheading:12794521... | lld:pubmed |
pubmed-article:12794521 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12794521 | pubmed:articleTitle | Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemia. | lld:pubmed |
pubmed-article:12794521 | pubmed:affiliation | Department of Pharmacy, Research Unit INSERM No. 379, France. | lld:pubmed |
pubmed-article:12794521 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12794521 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12794521 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:12794521 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:12794521 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:12794521 | pubmed:publicationType | Evaluation Studies | lld:pubmed |